Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
4/1/2000
1.
Phase I Study of KRN5500 (a Spicamycin Derivative) for Advanced Adult Solid Tumors (Summary Last Modified 04/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
DFCI-96019
NCI-T96-0001H, T96-0001
Last Modified:
3/1/2001
2.
Phase I Study of KRN5500 (NSC650426) in Patients With Solid Malignant Tumors (Summary Last Modified 03/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
15 and over
NCI
WSU-1294
NCI-T96-0004, NCT00002923, T96-0004
Last Modified:
1/26/2005
 
First Published:
6/1/2001
3.
Phase I Study of KRN5500 in Patients With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
DFCI-00102
NCI-1653, NCT00017238, 1653
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute